Henry Schein, Inc. signed an agreement to acquire an unknown majority interest in TriMed, Inc.
December 19, 2023
Share
Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc. on December 20, 2023. The transaction is subject to certain regulatory approvals and closing conditions and is expected to be completed in the first quarter of 2024. TriMed founders David Medoff, Chief Commercial Officer, and Robert Medoff, MD, Medical Advisor, will continue to be a part of the management team of TriMed and bring to Henry Schein.
TriMed had 2022 net sales of approximately $48 million.
Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:
- distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);
- other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services.
The United States account for 69.9% of net sales.Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:
- distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);
- other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services.
The United States account for 69.9% of net sales.